Register entry

Olpha AS

Data as of · How to read this entry

Registered sites
1
Active NDC listings
8
Live patents
0
Countries
1
Base
Latvia
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Olpha AS5 Rupnicu iela, Olaine, Olaines novads, LV-2114, Latvia (LVA)Active ingredient (API) manufacture3001672072644699498
Catalogue

Drug listings by form and route

8

8 active NDC listings: 8 bulk ingredient. By marketing category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 6, BULK INGREDIENT 2.

Dosage formNDCs
powder8
RouteNDCs
Labeller name on the listingNDCs
olpha as8
Catalogue

Marketed products

8
BrandGeneric nameForm / routeNDC
-AMANTADINE HYDROCHLORIDEpowder63818-0435BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-ARBACLOFENpowder63818-0001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-ARBACLOFENpowder63818-0002BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Anagrelide Hydrochloridepowder63818-0425BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-CHLOROBUTANOL HEMIHYDRATEpowder63818-0005BULK INGREDIENT
-Memantine Hydrochloridepowder63818-0004BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Rimantadine Hydrochloridepowder63818-0434BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-THALIDOMIDEpowder63818-0424BULK INGREDIENT
Enquiry

Common questions

Is Olpha AS FDA approved?
Olpha AS holds 1 FDA-registered establishment in Latvia. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Olpha AS's drugs manufactured?
The FDA register lists Olaines novads. Registered operations: active ingredient (API) manufacture.
What drugs does Olpha AS make?
8 products are listed under Olpha AS in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.